Riskpilot← Back to searchSign inGet full accessUV Medico A/S
A/SActiveCVR 42602582Bryghuspladsen 8, 3.Manufacture of lighting equipment · NACE 2740Est. 202126 employees
Revenue 2024
DKK -299K
-106% vs 2023
EBITDA margin
6067.8%
-122% vs 2023
Equity ratio
18.3%
Financial strength
Net profit 2024
DKK -14,5M
-101% vs 2023
| Revenue | DKK -299K | -106% |
| EBITDA | DKK -18,2M | -122% |
| Net profit | DKK -14,5M | -101% |
| Total assets | DKK 30,7M | +92% |
| Equity | DKK 5,6M | +10% |
| Employees | 26 | — |
Legal name
UV Medico A/S
CVR number
42602582
Legal form
Aktieselskab
NACE code
2740 · Manufacture of lighting equipment
Founded
16. august 2021
Share capital
DKK 400.000
Employees
26 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør sammen med bestyrelsesformanden eller af den samlede bestyrelse i forening
Company purpose
Selskabets formål er at drive virksomhed med produktion og salg af lyssystemer og udstyr til sterilisering og desinfektion i sundhedssektoren samt enhver virksomhed der efter det centrale ledelsesorgans skøn står i forbindelse hermed
Address
Bryghuspladsen 8, 3.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 75 | 4.946 | -299 |
| Staff expenses | -661 | -9.837 | -12.168 |
| EBITDA | -586 | -8.171 | -18.162 |
| Depreciation & amort. | -0 | -152 | -152 |
| EBIT | -586 | -8.323 | -18.314 |
| Net financials | -87 | -785 | -325 |
| Profit before tax | -673 | -9.108 | -18.639 |
| Tax | -133 | -1.882 | -4.136 |
| Net profit | -540 | -7.226 | -14.503 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 10.158 | 15.963 | 30.657 |
| Equity | 1.342 | 5.116 | 5.613 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 8.815 | 10.847 | 25.044 |
| Total debt | 8.815 | 10.847 | 25.044 |
EBITDA margin
-1816234700.0%
This company
15.8%
Market median
-11495156429% vs market
20222024
Equity ratio
18.3%
This company
38.2%
Market median
-52% vs market
20222024
Return on equity
-258.4%
This company
18.4%
Market median
-1504% vs market
20222024
Net profit margin
-1450338900.0%
This company
8.1%
Market median
-17905418619% vs market
20222024
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20222024
Debt / equity
4.46×
This company
0.62×
Market median
-619% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HN Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (2) | ||
CK Management | Management | 2024 – 2025 |
AS Management | Management | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2025 | |
| Chairman | 2026 | |
| Board of Directors | 2025 | |
| Board of Directors | 2026 | |
| Former (2) | ||
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2024 – 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BANDHOLM.EU HOLDING ApS
UV Medico A/S Board members of UV Medico A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Kanstrup Holm | Management | 0 companies |
| Henrik Nielsen | Chief Executive Officer | 0 companies |
| Anders Samuelsen | Management | 0 companies |
| Claus Steensen Sølje | Board of Directors | 0 companies |
| Torben Rene Larsen | Board of Directors | 0 companies |
| Kristian Villumsen | Chairman | 0 companies |
| Michael Nielsen | Board of Directors | 0 companies |
| Peter Johansen | Board of Directors | 0 companies |
| Johan Sebastian Schur | Board of Directors | 0 companies |
| Klaus Rudolf Langhoff-Roos | Board of Directors | 0 companies |